Soleimani, M., Thi, M., Janfaza, S., Ozcan, G., Mazurek, S., Ozgun, G., . . . Nappi, L. Circulating microRNA-155-3p levels predicts response to first line immunotherapy in patients with metastatic renal cell carcinoma. Nature Portfolio.
Chicago Style (17th ed.) CitationSoleimani, Maryam, et al. Circulating MicroRNA-155-3p Levels Predicts Response to First Line Immunotherapy in Patients with Metastatic Renal Cell Carcinoma. Nature Portfolio.
MLA (9th ed.) CitationSoleimani, Maryam, et al. Circulating MicroRNA-155-3p Levels Predicts Response to First Line Immunotherapy in Patients with Metastatic Renal Cell Carcinoma. Nature Portfolio.
Warning: These citations may not always be 100% accurate.